Lisa Pendlebury
Follow
Get notifications in MyBN when activity occurs.
Lisa Pendlebury
Vice President, Investor Relations & Communications / Mayne Pharma Group
Lisa Pendlebury has experience in business development, mergers and acquisitions, corporate strategy, investor relations, financial reporting, corporate governance, remuneration and sustainability across a number of industries.
She is an experienced executive who has worked in the pharmaceutical, consumer products and finance industries for over 20 years.
Ms Pendlebury started her career in investment banking at JP Morgan before moving to private equity with CVC Capital Partners. She held various roles in business development and strategy at Pacific Brands. Ms Pendlebury has worked in the pharmaceutical industry at Mayne Pharma since 2010, and has been an executive on the senior leadership team. She is the treasurer of EDFA, a not-for-profit organisation.
She is an experienced executive who has worked in the pharmaceutical, consumer products and finance industries for over 20 years.
Ms Pendlebury started her career in investment banking at JP Morgan before moving to private equity with CVC Capital Partners. She held various roles in business development and strategy at Pacific Brands. Ms Pendlebury has worked in the pharmaceutical industry at Mayne Pharma since 2010, and has been an executive on the senior leadership team. She is the treasurer of EDFA, a not-for-profit organisation.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 241st | Netwealth Group | 43% | 21% |
| 366th | Probiotec | 23% | 16% |
| 591st | Hansen Technologies | 5% | 11% |
| 808th | Charter Hall Retail REIT | -5% | 1% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 273rd |  | Hansen Technologies | $315.1m |
| 325th | | Probiotec | $214.6m |
| 326th | | Charter Hall Retail REIT | $214.4m |
| 328th | | Symbio | $211.9m |
| 329th | | Netwealth Group | $211.6m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Vice President, Investor Relations & Communications, Mayne Pharma Group | 14 Mar 2022 |
| NEW ROLE: Non-Executive Director, Hansen Technologies | 14 Mar 2022 |
